| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Recombx® CAR (Anti-Recoverin) Autoantibody Test
Test Code4684
Alias/See Also
LAB00293
CAR AB
RECOMBX CAR AUTOANTIBODY TEST
CANCER-ASSOCIATED RETINOPATHY (CAR)
CAR AB
RECOMBX CAR AUTOANTIBODY TEST
CANCER-ASSOCIATED RETINOPATHY (CAR)
CPT Codes
83520
Preferred Specimen
2 mL serum
Minimum Volume
0.5 mL
Other Acceptable Specimens
CSF collected in a sterile leak-proof container
Instructions
Serum must be separated from cells within 48 hours of collection.
Note: Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form.
Note: Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form.
Transport Container
Transport tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 72 hours
Refrigerated: 28 days
Frozen: 28 days
Refrigerated: 28 days
Frozen: 28 days
Methodology
Automated Nanoliter Scale Immunoassay
FDA Status
This test was developed and its analytical performance characteristics have been determined by Athena Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Tues, fri
Report Available
3-5 days
Reference Range
Serum
CSF
| Technical Results | <1:50 |
CSF
| Technical Results | <1:1 |
Clinical Significance
Anti-recoverin antibodies can be detected in patients with cancer-associated retinopathy (CAR). This semi-quantitative assay may be useful in monitoring therapeutic responses in select cases.
Performing Laboratory
| Athena Diagnostics, Inc. |
| 200 Forest Street, 2nd Floor |
| Marlborough, MA 01752-3023 |